Back
Standard BioTools Quote, Financials, Valuation and Earnings
Sponsored
LAB
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
63
LAB
Standard BioTools
Last Price:
2.10
Seasonality Move:
18.86%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Standard BioTools Price Quote
$2.10
Standard BioTools Key Stats
Buy
63
Standard BioTools (LAB)
is a Buy
Day range:
$1.99 - $2.11
52-week range:
$1.21 - $3.04
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.76
P/B ratio:
1.59%
Volume:
2.6M
Avg. volume:
1.6M
1-year change:
0.48%
Market cap:
$779.4M
Revenue:
$106.3M
EPS:
$-0.71
How Much Does Standard BioTools Make?
-
How Much Are Standard BioTools's Sales Annually?
LAB Revenues are $106.3M -
How Much Profit Does Standard BioTools's Make A Year?
LAB net income is -$74.7M
Is Standard BioTools Growing As A Company?
-
What Is Standard BioTools's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.77% -
What Is Standard BioTools's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Standard BioTools Stock Price Performance
-
Did Standard BioTools Stock Go Up Last Month?
Standard BioTools share price went up by 13.51% last month -
Did LAB's Share Price Rise Over The Last Year?
LAB share price rose by 0.48% over the past 1 year
What Is Standard BioTools 52-Week High & Low?
-
What Is Standard BioTools’s 52-Week High Share Price?
Standard BioTools has traded as high as $3.04 over the past 52 weeks -
What Is Standard BioTools’s 52-Week Low Share Price?
Standard BioTools has traded as low as $1.21 over the past 52 weeks
Standard BioTools Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Standard BioTools?
-
How Much Debt Does Standard BioTools Have?
Total long term debt quarterly is $55.2M -
How Much Cash Does Standard BioTools Have?
Cash and short term investments quarterly total is $366.3M -
What Is Standard BioTools’s Book Value Per Share?
Book value per share is 1.32
Is Standard BioTools Cash Flow Positive?
-
What Is LAB Cash Flow From Operations?
Cash flow from operations (TTM) is -$143.5M -
What Is Standard BioTools’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$49.1M -
What Is Standard BioTools’s Cash Flow From Investing?
Cash flow from investing (TTM) is $324.3M
Standard BioTools Return On Invested Capital
-
Is Management Doing A Good Job?
LAB return on invested capital is -39.17% -
What Is Standard BioTools Return On Assets?
ROA measures how assets are converting to revenues and is -22.01% -
What Is LAB Return On Equity?
ROE is a measure of profitability and is -48.03%
Standard BioTools Earnings Date & Stock Price
-
What Is Standard BioTools's Stock Price Today?
A single share of LAB can be purchased today for 2.10 -
What Is Standard BioTools’s Stock Symbol?
Standard BioTools trades on the nasdaq under the ticker symbol: LAB -
When Is Standard BioTools’s Next Earnings Date?
The next quarterly earnings date for Standard BioTools is scheduled on February 28, 2025 -
When Is LAB's next ex-dividend date?
Standard BioTools's next ex-dividend date is November 5, 2024 -
How To Buy Standard BioTools Stock?
You can buy Standard BioTools shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Standard BioTools Competitors
-
Who Are Standard BioTools's Competitors?
Below is a list of companies who compete with Standard BioTools or are related in some way:
Standard BioTools Dividend Yield
-
What Is LAB Dividend Yield?
Standard BioTools’s dividend yield currently is 0% -
What Is Standard BioTools’s Payout Ratio?
Standard BioTools’s payout ratio is 0% -
When Did Standard BioTools Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Standard BioTools’s Dividend Per Share?
Standard BioTools pays a dividend of $0.00 per share
Standard BioTools Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 53.87% |
Revenue: | 77.27% | 9.68% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 3.08 |
Upside from Last Price: | 46.83% |